Axcella Health Files for $86 Million IPO

Early stage biotech, Axcella Health, has filed for an $86 million IPO. The initial filing documents do not provide the number of shares in the offering or the expected price range. The company has appiled to trade under the symbol, “AXLA.”Current Investors include Flagship Pioneering, Fidelity, and Nestle Health Science.